Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.22 | N/A |
| PEG Ratio (TTM) | 0.58 | N/A |
| P/S Ratio (TTM) | 2.82 | N/A |
| P/B Ratio (TTM) | 1.37 | N/A |
| P/FCF Ratio (TTM) | 8.29 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.61 | N/A |
| Price to 5YR AVG FCF Ratio | 9.73 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.61% | N/A |
| ROE (TTM) | 7.05% | N/A |
| Net Profit Margin (TTM) | 14.09% | N/A |
| ROIC 5YR AVG | 18.12% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 320.17% | 25.48% | 9.40% |
| Revenue | 13.32% | 12.82% | 8.38% |
| Net Income | 333.10% | 33.79% | 14.55% |
| Cash Flow | 23.68% | 1,493.36% | 907.56% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.39 | N/A |
| Quick Ratio (TTM) | 0.39 | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 0.49 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 1.65 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.17% | N/A |